Predictive testing for persons at risk for homozygosity for CAG expansion in the Huntington disease gene [4]

Clinical Genetics

Volumn 64, Issue 6, 2003, Pages 524-525

  Squitieri, Ferdinando ^a   Almqvist, E W ^b   Cannella, M ^b   Cislaghi, G ^b   Hayden, M R ^b  

^a IRCCS NEUROMED   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE;

ALLELE; COHORT ANALYSIS; CONSANGUINEOUS MARRIAGE; CONTROLLED STUDY; FAMILY STUDY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUNTINGTON CHOREA; ITALY; LETTER; PREDICTION; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT;

GENETIC COUNSELING; GENETIC SCREENING; HOMOZYGOTE; HUMANS; HUNTINGTON DISEASE; ITALY; MUTATION;

EID: 0344740649     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0004.2003.00155.x     Document Type: Letter

References (4)

1. Squitieri F, Gellera C, Cannella M et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 2003: 126: 946-955.
2. Benjamin CM, Adam S, Wiggins S et al. Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet 1994: 55: 606-617.
3. International Huntington Association and World Federation of Neurology research group of Huntington's chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994: 44: 1533-1536.
4. Cannella M, Simonelli M, D'Alessio C, Pierelli F, Ruggieri S, Squitieri F. Presymptomatic tests in Huntington's disease and dominant ataxias. Neurol Sci 2001: 22: 55-56.